FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093378061> ?p ?o ?g. }

• W2093378061 endingPage "71" @default.
• W2093378061 startingPage "62" @default.
• W2093378061 abstract "Immunogenicity is a major issue of concern for monoclonal antibodies used in human diseases and is by default mainly determined in non-human primates (NHP), as target molecules are considered most similar in NHP compared to human. In this manuscript the predictive value of immunogenicity testing in minipigs for human safety is evaluated, as the immune system of the pig is functionally similar to that in other mammalian species. Adalimumab and infliximab (both monoclonal antibodies blocking TNFα) were used as model substances. Female Göttingen minipigs (4/group) were treated every other week with low (0.1 mg/kg), mid (1.0 mg/kg), or high dose (5 mg/kg) adalimumab or 5 mg/kg infliximab subcutaneous (SC) over a period of 8 weeks. After first and last dosing, pharmacokinetic analysis was performed. Anti-drug antibodies (ADAs) were measured on several time points. Furthermore, hematology, clinical chemistry, body weight, clinical signs, and histopathology of several organs were evaluated. No signs of toxicity of the treatments were observed in the limited organs and tissues collected. Eleven out of 12 minipigs treated with adalimumab elicited a detectable ADA response. Induction of ADA was correlated with decreased plasma levels of adalimumab. Infliximab clearance was comparable after first and last dose. Therefore, the presence of ADA directed to infliximab was considered highly unlikely. It was concluded that the minipig and NHP showed comparable suitability for immunogenicity prediction in humans. More studies with other biopharmaceutical products are needed to strengthen the status of the minipig as an alternative model for immunotoxicity testing including immunogenicity." @default.
• W2093378061 created "2016-06-24" @default.
• W2093378061 creator A5007524730 @default.
• W2093378061 creator A5027069639 @default.
• W2093378061 creator A5029733252 @default.
• W2093378061 creator A5034502895 @default.
• W2093378061 creator A5046590750 @default.
• W2093378061 creator A5050087953 @default.
• W2093378061 creator A5058198903 @default.
• W2093378061 creator A5077094979 @default.
• W2093378061 creator A5081174471 @default.
• W2093378061 creator A5084677467 @default.
• W2093378061 date "2013-06-05" @default.
• W2093378061 modified "2023-09-26" @default.
• W2093378061 title "The minipig as an alternative non-rodent model for immunogenicity testing using the TNFα blockers adalimumab and infliximab" @default.
• W2093378061 cites W1964924603 @default.
• W2093378061 cites W1975033484 @default.
• W2093378061 cites W1977357831 @default.
• W2093378061 cites W1985123137 @default.
• W2093378061 cites W1997999969 @default.
• W2093378061 cites W2008716770 @default.
• W2093378061 cites W2010444471 @default.
• W2093378061 cites W2013758511 @default.
• W2093378061 cites W2017883234 @default.
• W2093378061 cites W2032160423 @default.
• W2093378061 cites W2038302201 @default.
• W2093378061 cites W2047275628 @default.
• W2093378061 cites W2051129711 @default.
• W2093378061 cites W2057018793 @default.
• W2093378061 cites W2062826169 @default.
• W2093378061 cites W2064876070 @default.
• W2093378061 cites W2065897299 @default.
• W2093378061 cites W2096835788 @default.
• W2093378061 cites W2105116489 @default.
• W2093378061 cites W2114029270 @default.
• W2093378061 cites W2117561430 @default.
• W2093378061 cites W2119046820 @default.
• W2093378061 cites W2122295866 @default.
• W2093378061 cites W2129651656 @default.
• W2093378061 cites W2133541603 @default.
• W2093378061 cites W2134240536 @default.
• W2093378061 cites W2149065814 @default.
• W2093378061 doi "https://doi.org/10.3109/1547691x.2013.796023" @default.
• W2093378061 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23738746" @default.
• W2093378061 hasPublicationYear "2013" @default.
• W2093378061 type Work @default.
• W2093378061 sameAs 2093378061 @default.
• W2093378061 citedByCount "18" @default.
• W2093378061 countsByYear W20933780612014 @default.
• W2093378061 countsByYear W20933780612015 @default.
• W2093378061 countsByYear W20933780612016 @default.
• W2093378061 countsByYear W20933780612017 @default.
• W2093378061 countsByYear W20933780612018 @default.
• W2093378061 countsByYear W20933780612019 @default.
• W2093378061 countsByYear W20933780612020 @default.
• W2093378061 countsByYear W20933780612021 @default.
• W2093378061 countsByYear W20933780612022 @default.
• W2093378061 crossrefType "journal-article" @default.
• W2093378061 hasAuthorship W2093378061A5007524730 @default.
• W2093378061 hasAuthorship W2093378061A5027069639 @default.
• W2093378061 hasAuthorship W2093378061A5029733252 @default.
• W2093378061 hasAuthorship W2093378061A5034502895 @default.
• W2093378061 hasAuthorship W2093378061A5046590750 @default.
• W2093378061 hasAuthorship W2093378061A5050087953 @default.
• W2093378061 hasAuthorship W2093378061A5058198903 @default.
• W2093378061 hasAuthorship W2093378061A5077094979 @default.
• W2093378061 hasAuthorship W2093378061A5081174471 @default.
• W2093378061 hasAuthorship W2093378061A5084677467 @default.
• W2093378061 hasBestOaLocation W20933780611 @default.
• W2093378061 hasConcept C111113717 @default.
• W2093378061 hasConcept C112705442 @default.
• W2093378061 hasConcept C126322002 @default.
• W2093378061 hasConcept C159654299 @default.
• W2093378061 hasConcept C17991360 @default.
• W2093378061 hasConcept C203014093 @default.
• W2093378061 hasConcept C2777138892 @default.
• W2093378061 hasConcept C2777288759 @default.
• W2093378061 hasConcept C2780132546 @default.
• W2093378061 hasConcept C2780868878 @default.
• W2093378061 hasConcept C542903549 @default.
• W2093378061 hasConcept C71924100 @default.
• W2093378061 hasConcept C98274493 @default.
• W2093378061 hasConceptScore W2093378061C111113717 @default.
• W2093378061 hasConceptScore W2093378061C112705442 @default.
• W2093378061 hasConceptScore W2093378061C126322002 @default.
• W2093378061 hasConceptScore W2093378061C159654299 @default.
• W2093378061 hasConceptScore W2093378061C17991360 @default.
• W2093378061 hasConceptScore W2093378061C203014093 @default.
• W2093378061 hasConceptScore W2093378061C2777138892 @default.
• W2093378061 hasConceptScore W2093378061C2777288759 @default.
• W2093378061 hasConceptScore W2093378061C2780132546 @default.
• W2093378061 hasConceptScore W2093378061C2780868878 @default.
• W2093378061 hasConceptScore W2093378061C542903549 @default.
• W2093378061 hasConceptScore W2093378061C71924100 @default.
• W2093378061 hasConceptScore W2093378061C98274493 @default.
• W2093378061 hasIssue "1" @default.
• W2093378061 hasLocation W20933780611 @default.
• W2093378061 hasLocation W20933780612 @default.

• next